Keyphrases
Type 2 Diabetes Prevention
100%
Heterogeneous Treatment Effects
100%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
GLP-1 Receptor Agonist
100%
Randomized Controlled Trial
28%
Methodological Limitations
28%
Cardiovascular Outcomes
28%
Glycemic Response
28%
Clinical Features
28%
Agonist Treatment
28%
Biological Characteristics
28%
Renal Outcome
28%
Precision Medicine
28%
Clinical Outcomes
14%
Robustness Evaluation
14%
Meta-analysis
14%
Type 2 Diabetes Mellitus (T2DM)
14%
Clinical Care
14%
Insulin Secretion
14%
Clinically Significant
14%
Renal Function
14%
Clinical Decisions
14%
Antihyperglycemic
14%
Treatment Assessment
14%
Meta-analysis Study
14%
Glycemic Outcomes
14%
Medicine and Dentistry
Receptor
100%
Maturity Onset Diabetes of the Young
100%
Systematic Review
100%
Treatment Effect
100%
Sodium Glucose Cotransporter 2 Inhibitor
100%
Glycemic
42%
Randomized Controlled Trial
28%
Observational Study
28%
Cardiovascular System
28%
Meta-Analysis
28%
Personalized Medicine
28%
Combination Therapy
14%
Insulin Release
14%
Kidney Function
14%
Post-Hoc Analysis
14%